InvestorsHub Logo
Followers 22
Posts 4084
Boards Moderated 0
Alias Born 04/29/2016

Re: buckysherm post# 8363

Wednesday, 12/14/2016 3:48:12 PM

Wednesday, December 14, 2016 3:48:12 PM

Post# of 233052
Exactly! That's what concerns me. GILD is cash rich and could take that gamble at .68 pps base. Nader needs to protect a hostile Take Over by escalating the pps. Certainly a company like GILD would rather see Data first, However, if they could steal the company for Dirt cheap based on high probability of good Adjunct results..they will. It has happened to various companies in the past. Nader, is far from a Wall Street Financial wizard! Correct me if I am wrong, but I see NO POISON Pill in place to ward off A desperate R&D starved Gilead!! Nadar, willingly staying on the vulnerable OTC market, while concomitantly conducting P3 Pivotal trials.... baffles me to no End!! Very Frustrating. We should at least hire a competent CFO!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News